Doctors at NewYork-Presbyterian/Columbia are looking to interventional endocrinology, an emerging specialty that uses percutaneous, image-guided, less-invasive procedures to address endocrine disorders that offers an alternative to surgery.

Under the direction of Dr. Thomas J. Fahey, III, researchers at Weill Cornell Medicine have identified the use of gene expression analysis to discriminate benign and malignant thyroid nodules.

Dr. O’Dell is celebrated for his key role in both expanding and bringing a collaborative spirit to the Department.

Research is a key component of the Weight Control Center. Dr. Korner is the principal investigator of an NIH-funded study to understand the hormonal regulation of appetite and energy balance.

Martin B. Leon, MD, Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian/Columbia University Irving Medical Center, has been awarded the 2019 Lifetime Achievement Award by the American College of Cardiology (ACC) in honor of his contributions to the field of interventional cardiology.

A multicenter clinical trial has found that transcatheter aortic valve replacement (TAVR) performed better than open heart surgery in patients with severe aortic stenosis at low surgical risk.

Renowned cardiothoracic surgeon Stephanie L. Mick, MD, has joined the Department of Cardiothoracic Surgery at NewYork-Presbyterian/ Weill Cornell Medical Center as Director of Robotic and Minimally Invasive Cardiac Surgery.

Dr. Nir Uriel, an internationally recognized leader in heart failure, mechanical circulatory support, and heart transplantation, will oversee heart failure programs at NewYork-Presbyterian’s campuses in Manhattan, Queens, Brooklyn, and Westchester.